On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson’s Disease

On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson’s Disease

Protein aggregation, mitochondrial dysfunction, iron dyshomeostasis, increased oxidative damage and inflammation are pathognomonic features of Parkinson’s disease (PD) and other neurodegenerative disorders characterized by abnormal iron accumulation. Moreover, the existence of positive feed-back loo...

Full description

Bibliographic Details
Main Authors:	Olimpo García-Beltrán, Pamela J. Urrutia, Marco T. Núñez
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Antioxidants
Subjects:	Parkinson’s disease iron dyshomeostasis clinical trials multifunctional drugs
Online Access:	https://www.mdpi.com/2076-3921/12/2/214

Similar Items

Calcium channels and iron metabolism: A redox catastrophe in Parkinson's disease and an innovative path to novel therapies?
by: Matthew K. Boag, et al.
Published: (2021-11-01)

The Role Played by Ferroptosis in Osteoarthritis: Evidence Based on Iron Dyshomeostasis and Lipid Peroxidation
by: Shaoyun Zhang, et al.
Published: (2022-08-01)

Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis
by: Núria DeGregorio-Rocasolano, et al.
Published: (2019-02-01)

Altered Expression of Mitoferrin and Frataxin, Larger Labile Iron Pool and Greater Mitochondrial DNA Damage in the Skeletal Muscle of Older Adults
by: Anna Picca, et al.
Published: (2020-12-01)

Iron dyshomeostasis and ferroptosis in Alzheimer’s disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD
by: Yuan Zhang, et al.
Published: (2022-09-01)

Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine
by: Benson O. A. Botchway, et al.
Published: (2023-05-01)

Overlapping Receptor-Based Pathogenic Cascades in Degenerative Disease: Implications Ranging from Tumor Targeting to Aging and Dementia Therapeutics
by: Joseph S. D’Arrigo
Published: (2024-02-01)

The potential involvement of inhaled iron (Fe) in the neurotoxic effects of ultrafine particulate matter air pollution exposure on brain development in mice
by: Marissa Sobolewski, et al.
Published: (2022-08-01)

Calcium Dyshomeostasis Drives Pathophysiology and Neuronal Demise in Age-Related Neurodegenerative Diseases
by: Gerard Griffioen
Published: (2023-08-01)

In Vitro and In Vivo Nutraceutical Characterization of Two Chickpea Accessions: Differential Effects on Hepatic Lipid Over-Accumulation
by: Mariangela Centrone, et al.
Published: (2020-03-01)

Alterations in iron content, iron-regulatory proteins and behaviour without tau pathology at one year following repetitive mild traumatic brain injury
by: Sydney M. A. Juan, et al.
Published: (2023-07-01)

Early-stage mapping of macromolecular content in APPNL-F mouse model of Alzheimer’s disease using nuclear Overhauser effect MRI
by: Anshuman Swain, et al.
Published: (2023-10-01)

Imbalances in Copper or Zinc Concentrations Trigger Further Trace Metal Dyshomeostasis in Amyloid-Beta Producing Caenorhabditis elegans
by: Ada Metaxas
Published: (2021-10-01)

Multifunctional redundancy: Impossible or undetected?
by: Bridget E. White, et al.
Published: (2023-08-01)

Weakly Picard Pairs of Multifunctions
by: Valeriu Popa
Published: (2010-01-01)

Clinical features of Parkinson’s disease patients are associated with therapeutic misconception and willingness to participate in clinical trials
by: Emmi Reijula, et al.
Published: (2017-09-01)

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
by: Marco T. Nuñez, et al.
Published: (2018-10-01)

Antioxidant Therapeutics in Parkinson’s Disease: Current Challenges and Opportunities
by: Ana Patricia Duarte-Jurado, et al.
Published: (2021-03-01)

Upper and lower cl-supercontinuous multifunctions
by: J.K. Kohli, et al.
Published: (2013-07-01)

Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease
by: Chunhui Huang, et al.
Published: (2019-04-01)

Magnesium Deficiency and Cardiometabolic Disease
by: Remi Fritzen, et al.
Published: (2023-05-01)

Unraveling Aβ-Mediated Multi-Pathway Calcium Dynamics in Astrocytes: Implications for Alzheimer’s Disease Treatment From Simulations
by: Langzhou Liu, et al.
Published: (2021-10-01)

Vitamin D in Parkinson's disease: A systematic review of randomized controlled trials
by: Paraskevi Detopoulou, et al.
Published: (2023-12-01)

Alzheimer's and Parkinson's disease therapies in the clinic
by: Puja Chopade, et al.
Published: (2023-01-01)

Roadmap on multifunctional materials for drug delivery
by: Benjamin Nottelet, et al.
Published: (2023-01-01)

On lower semicontinuity of the restricted center multifunction
by: Devidas Pai
Published: (2009-02-01)

On lower semicontinuity of the restricted center multifunction
by: Devidas Pai
Published: (2009-02-01)

Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
by: Camila Henriques de Aquino, et al.
Published: (2021-08-01)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
by: Zhang H, et al.
Published: (2019-07-01)

New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
by: Kamila Czarnecka, et al.
Published: (2018-01-01)

Multifunctionality of Organic Farming: Case Study from Southern Poland
by: Śpiewak Ruta
Published: (2016-03-01)

Multifunctionality of agriculture: a Brazilian perspective
by: Tarita Schnitman
Published: (2020-01-01)

On irresolute multifunctions and related topological games
by: Sewalem Ghanem
Published: (2022-08-01)

Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease
by: Xinyu Hu, et al.
Published: (2023-02-01)

Advancing Personalized Medicine in Common Forms of Parkinson’s Disease through Genetics: Current Therapeutics and the Future of Individualized Management
by: Xylena Reed, et al.
Published: (2021-03-01)

Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease
by: Hu Y, et al.
Published: (2021-06-01)

A multifunctional drug consisting of tetracycline conjugated with odanacatib for efficient periodontitis therapy
by: Dengke Li, et al.
Published: (2022-10-01)

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease
by: Jaime Kulisevsky, et al.
Published: (2022-06-01)

Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
by: Thomas F. Tropea, et al.
Published: (2021-08-01)

The Genetics of Parkinson’s Disease and Implications for Clinical Practice
by: Jacob Oliver Day, et al.
Published: (2021-06-01)